Zobrazeno 1 - 10
of 85
pro vyhledávání: '"M. Trebo"'
Autor:
T. Hautz, S. Salcher, M. Fodor, G. Sturm, S. Ebner, A. Mair, M. Trebo, G. Untergasser, S. Sopper, B. Cardini, A. Martowicz, J. Hofmann, S. Daum, M. Kalb, T. Resch, F. Krendl, A. Weissenbacher, G. Otarashvili, P. Obrist, B. Zelger, D. Öfner, Z. Trajanoski, J. Troppmair, R. Oberhuber, A. Pircher, D. Wolf, S. Schneeberger
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract Normothermic machine perfusion (NMP) has emerged as an innovative organ preservation technique. Developing an understanding for the donor organ immune cell composition and its dynamic changes during NMP is essential. We aimed for a comprehen
Externí odkaz:
https://doaj.org/article/6155b582850748e78479b29cb2a4182a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pediatric Blood & Cancer. 46:66-71
Background To evaluate the clinical course and outcome of infants with Langerhans cell histiocytosis (LCH) involving skin and to estimate the incidence of progression to multi-system (M-S) disease in those with isolated skin involvement. Methods A re
Autor:
Benjamin Z. Koplewitz, Stanley Calderwood, Monika M. Trebo, Robert J. Klaassen, Sheila Weitzman
Publikováno v:
Journal of Pediatric Hematology/Oncology. 25:8-13
Purpose: We did a population-based study of children with high-risk neuroblastoma to determine their survival and look for factors that had an impact on survival. Methods: We carried out a retrospective cohort study of patients diagnosed in Ontario f
Autor:
Michael Dworzak, Helmut Gadner, Nora Mühlegger, M. Trebo, Alfred Reiter, Ernst Horcher, Georg Mann, Andishe Attarbaschi
Publikováno v:
Journal of Pediatric Surgery. 37:1470-1475
Background: Within the last 20 years, the role of surgery in the management of pediatric B-cell non-Hodgkin's lymphoma (B-NHL) has changed substantially. Along with the assignment of risk-adjusted therapy and specific treatment protocols, surgical pr
Autor:
Oskar A. Haas, Eva R. Grümayer-Panzer, Helmut Gadner, Georg Mann, Michael Dworzak, M. Trebo, Thomas Lion
Publikováno v:
British Journal of Haematology. 118:559-562
Mature B-cell or Burkitt’s-cell leukemias presenting with a L3 morphology according to the FAB classification (Bennett et al., 1976), and surface immunoglobulins together with B-cell markers have generally a good prognosis (Patte et al, 1991; Reite
Autor:
Arjan C. Lankester, Jan Stary, Robbert G. M. Bredius, Marc Bierings, C.M. Niemeyer, Marco Zecca, Marry van den Heuvel, M. Trebo, Andrica C H de Vries, Franco Locatelli
Publikováno v:
Haematologica, 94(2), 302-304. Ferrata Storti Foundation
Background: Juvenile myelomonocytic leukemia (JMML) is a rare malignant myeloid disorder in childhood, for which stem cell transplantation is currently the only curative treatment option. Although unrelated donor umbilical cord blood transplantations
Autor:
Charlotte M. Niemeyer, Peter Noellke, Elisabeth R. van Wering, Gudrun Göhring, Jan Stary, Brigitte Schlegelberger, H. Berna Beverloo, Marco Zecca, Brigitte Strahm, Henrik Hasle, Alexandra Fischer, Kyra Michalova, Laura Sainati, Franco Locatelli, Oskar A. Haas, M. Trebo, Jochen Harbott, Eva Bergstraesser, Marry M. van den Heuvel-Eibrink, Gitte Kerndrup, David R. Betts
Publikováno v:
Blood, 116(19), 3766-3769. American Society of Hematology
Göhring, G, Michalova, K, Beverloo, H B, Betts, D, Harbott, J, Haas, O A, Kerndrup, G, Sainati, L, Bergstraesser, E, Hasle, H, Stary, J, Trebo, M, van den Heuvel-Eibrink, M M, Zecca, M, van Wering, E R, Fischer, A, Noellke, P, Strahm, B, Locatelli, F, Niemeyer, C M & Schlegelberger, B 2010, ' Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome ', Blood, vol. 116, no. 19, pp. 3766-9 . https://doi.org/10.1182/blood-2010-04-280313
Göhring, G, Michalova, K, Beverloo, H B, Betts, D, Harbott, J, Haas, O A, Kerndrup, G, Sainati, L, Bergstraesser, E, Hasle, H, Stary, J, Trebo, M, van den Heuvel-Eibrink, M M, Zecca, M, van Wering, E R, Fischer, A, Noellke, P, Strahm, B, Locatelli, F, Niemeyer, C M & Schlegelberger, B 2010, ' Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome ', Blood, vol. 116, no. 19, pp. 3766-9 . https://doi.org/10.1182/blood-2010-04-280313
To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluat